increased sensitivity to xenobiotic induced morbidity/mortality_Tcra-J<tm1Tgi>/Tcra-J<tm1Tgi>

http://metadb.riken.jp/0009766I129S1Sv129X1SvJC57BL6TcraJtm1TgiTcraJtm1TgiTcraJtm1Tgi

increased sensitivity to xenobiotic induced morbidity/mortality_Tcra-J<tm1Tgi>/Tcra-J<tm1Tgi>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• T cell receptor alpha, joining region
  http://metadb.riken.jp/db/mgi_rdf/MGI:98555

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tcra-J<tm1Tgi>/Tcra-J<tm1Tgi>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tcra-J<tm1Tgi>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S1/Sv * 129X1/SvJ * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased sensitivity to xenobiotic induced morbidity/mortality
  http://purl.obolibrary.org/obo/MP_0009766

文献

http://purl.org/net/cito/citesAsAuthority

• Toru. Kimura, et.al., Treatment with alpha-galactosylceramide attenuates the development of bleomycin-induced pulmonary fibrosis., Journal of immunology (Baltimore, Md. : 1950), 2004, 172
  http://rdf.ncbi.nlm.nih.gov/pubmed/15100325